Suppr超能文献

急性多聚谷氨酰胺表达在可诱导的小鼠模型中揭示了泛素/蛋白酶体系统损伤和归因于聚集体形成的永久性恢复。

Acute polyglutamine expression in inducible mouse model unravels ubiquitin/proteasome system impairment and permanent recovery attributable to aggregate formation.

机构信息

Centro de Biologia Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas, Universidad Autonoma de Madrid and CiberNed, Madrid, Spain.

出版信息

J Neurosci. 2010 Mar 10;30(10):3675-88. doi: 10.1523/JNEUROSCI.5673-09.2010.

Abstract

The presence of intracellular ubiquitylated inclusions in neurodegenerative disorders and the role of the ubiquitin/proteasome system (UPS) in degrading abnormal hazardous proteins have given rise to the hypothesis that UPS-impairment underlies neurodegenerative processes. However, this remains controversial for polyglutamine disorders such as Huntington disease (HD). Whereas studies in cellular models have provided evidence in favor of UPS-impairment attributable to expression of the N-terminal fragment of mutant huntingtin (N-mutHtt), similar studies on mouse models failed to do so. Furthermore, we have recently shown that the increase in polyubiquitin conjugates reported in the brain of N-mutHtt mice occurs in the absence of a general UPS-impairment. In the present study we aim to clarify the potential of N-mutHtt to impair UPS function in vivo as well as the mechanisms by which neurons may adapt after prolonged exposure to N-mutHtt in genetic models. By combining UPS reporter mice with an inducible mouse model of HD, we demonstrate for the first time polyglutamine-induced global UPS-impairment in vivo. UPS-impairment occurred transiently after acute N-mutHtt expression and restoration correlated with appearance of inclusion bodies (IBs). Consistently, UPS recovery did not take place when IB formation was prevented through administration of N-mutHtt aggregation-inhibitors in both cellular and animal models. Finally, no UPS-impairment was detected in old mice constitutively expressing N-mutHtt despite the age-associated decrease in brain proteasome activity. Therefore, our data reconcile previous contradictory reports by showing that N-mutHtt can indeed impair UPS function in vivo and that N-mutHtt aggregation leads to long lasting restoration of UPS function.

摘要

在神经退行性疾病中存在细胞内泛素化包含物,以及泛素/蛋白酶体系统 (UPS) 在降解异常危险蛋白质中的作用,这使得 UPS 损伤是神经退行性过程的基础这一假说得以产生。然而,对于亨廷顿病 (HD) 等多聚谷氨酰胺疾病来说,这仍然存在争议。尽管细胞模型中的研究提供了证据支持由于表达突变型 huntingtin 的 N 端片段 (N-mutHtt) 导致的 UPS 损伤,但类似的小鼠模型研究未能证明这一点。此外,我们最近表明,在 N-mutHtt 小鼠大脑中报道的多泛素化缀合物的增加发生在没有普遍 UPS 损伤的情况下。在本研究中,我们旨在阐明 N-mutHtt 在体内损伤 UPS 功能的潜力,以及神经元在遗传模型中长时间暴露于 N-mutHtt 后可能适应的机制。通过将 UPS 报告小鼠与 HD 的诱导型小鼠模型相结合,我们首次在体内证明了多聚谷氨酰胺诱导的全 UPS 损伤。急性 N-mutHtt 表达后 UPS 损伤短暂发生,并且恢复与包含体 (IB) 的出现相关。一致地,在细胞和动物模型中通过给予 N-mutHtt 聚集抑制剂来防止 IB 形成时,UPS 恢复没有发生。最后,尽管与年龄相关的大脑蛋白酶体活性下降,但在持续表达 N-mutHtt 的老年小鼠中未检测到 UPS 损伤。因此,我们的数据通过显示 N-mutHtt 确实可以在体内损伤 UPS 功能,并且 N-mutHtt 聚集导致 UPS 功能的持久恢复,从而调和了先前的矛盾报告。

相似文献

2
Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment.
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13986-91. doi: 10.1073/pnas.0906463106. Epub 2009 Jul 30.
3
Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies.
FEBS Lett. 2014 Jan 3;588(1):151-9. doi: 10.1016/j.febslet.2013.11.023. Epub 2013 Nov 26.
5
Global changes to the ubiquitin system in Huntington's disease.
Nature. 2007 Aug 9;448(7154):704-8. doi: 10.1038/nature06022.
7
Single neuron ubiquitin-proteasome dynamics accompanying inclusion body formation in huntington disease.
J Biol Chem. 2009 Feb 13;284(7):4398-403. doi: 10.1074/jbc.M806269200. Epub 2008 Dec 10.
8
Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments.
Hum Mol Genet. 2010 Jun 15;19(12):2445-55. doi: 10.1093/hmg/ddq127. Epub 2010 Mar 30.
10
Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice.
J Cell Biol. 2008 Mar 24;180(6):1177-89. doi: 10.1083/jcb.200709080.

引用本文的文献

1
Pin1-Catalyzed Conformation Changes Regulate Protein Ubiquitination and Degradation.
Cells. 2024 Apr 23;13(9):731. doi: 10.3390/cells13090731.
2
The Emerging Landscape of Natural Small-molecule Therapeutics for Huntington's Disease.
Curr Neuropharmacol. 2023;21(4):867-889. doi: 10.2174/1570159X21666230216104621.
3
Reduction in PA28αβ activation in HD mouse brain correlates to increased mHTT aggregation in cell models.
PLoS One. 2022 Dec 27;17(12):e0278130. doi: 10.1371/journal.pone.0278130. eCollection 2022.
4
Cytosolic stress granules relieve the ubiquitin-proteasome system in the nuclear compartment.
EMBO J. 2023 Feb 1;42(3):e111802. doi: 10.15252/embj.2022111802. Epub 2022 Dec 27.
5
Altered Cholesterol Homeostasis in Huntington's Disease.
Front Aging Neurosci. 2022 Apr 19;14:797220. doi: 10.3389/fnagi.2022.797220. eCollection 2022.
6
Passive immunization against phosphorylated tau improves features of Huntington's disease pathology.
Mol Ther. 2022 Apr 6;30(4):1500-1522. doi: 10.1016/j.ymthe.2022.01.020. Epub 2022 Jan 17.
7
Fluc-EGFP reporter mice reveal differential alterations of neuronal proteostasis in aging and disease.
EMBO J. 2021 Oct 1;40(19):e107260. doi: 10.15252/embj.2020107260. Epub 2021 Aug 19.
9
Neuron type-specific increase in lamin B1 contributes to nuclear dysfunction in Huntington's disease.
EMBO Mol Med. 2021 Feb 5;13(2):e12105. doi: 10.15252/emmm.202012105. Epub 2020 Dec 28.
10
Targeting Tau to Treat Clinical Features of Huntington's Disease.
Front Neurol. 2020 Nov 19;11:580732. doi: 10.3389/fneur.2020.580732. eCollection 2020.

本文引用的文献

2
Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment.
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13986-91. doi: 10.1073/pnas.0906463106. Epub 2009 Jul 30.
3
A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease.
Biochim Biophys Acta. 2009 Jul;1792(7):664-75. doi: 10.1016/j.bbadis.2009.01.012. Epub 2009 Feb 3.
5
Single neuron ubiquitin-proteasome dynamics accompanying inclusion body formation in huntington disease.
J Biol Chem. 2009 Feb 13;284(7):4398-403. doi: 10.1074/jbc.M806269200. Epub 2008 Dec 10.
7
Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity.
Genes Dev. 2008 Dec 1;22(23):3308-19. doi: 10.1101/gad.1673408. Epub 2008 Nov 17.
10
A common motif targets huntingtin and the androgen receptor to the proteasome.
J Biol Chem. 2008 Aug 29;283(35):23950-5. doi: 10.1074/jbc.M800467200. Epub 2008 Jun 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验